Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 9.53 CAD Market Closed
Market Cap: 3.5B CAD

Bausch Health Companies Inc
Other Non-Cash Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Bausch Health Companies Inc
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
Bausch Health Companies Inc
TSX:BHC
Other Non-Cash Items
$8m
CAGR 3-Years
N/A
CAGR 5-Years
-66%
CAGR 10-Years
-38%
Canopy Growth Corp
TSX:WEED
Other Non-Cash Items
CA$244.3m
CAGR 3-Years
-52%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Aurora Cannabis Inc
TSX:ACB
Other Non-Cash Items
CA$34m
CAGR 3-Years
-72%
CAGR 5-Years
-59%
CAGR 10-Years
18%
Sundial Growers Inc
NASDAQ:SNDL
Other Non-Cash Items
CA$96.2m
CAGR 3-Years
-25%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Other Non-Cash Items
-$11m
CAGR 3-Years
N/A
CAGR 5-Years
45%
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Other Non-Cash Items
CA$11.2m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bausch Health Companies Inc
Glance View

Bausch Health Companies Inc. stands as a prominent player in the global healthcare arena, with its roots stretching back over a century. Originally known as Valeant Pharmaceuticals, the firm has undergone significant transformation, focusing on a diverse array of health-related products and innovations. The company operates primarily in three segments: Bausch + Lomb/International, Salix, and Ortho Dermatologics. Each of these divisions articulates its commitment to enhancing patients' lives through high-quality products that address the complex challenges of eye care, gastroenterology, and dermatology, respectively. The Bausch + Lomb sector, named after its foundational company, is recognized globally for its wealth of eye health products, including contact lenses, lens care products, and ophthalmic pharmaceuticals. This sector is integral to Bausch Health's revenue stream, contributing significantly through its diverse portfolio of over-the-counter and prescription offerings. At its core, Bausch Health has honed a business model centered around acquiring and developing specialty pharmaceuticals and health-enhancing technologies. Through strategic acquisitions, partnerships, and internal research, the company curates a vast pipeline of treatments and solutions. Revenue generation for Bausch Health is intrinsically linked to its global market footprint, operating in more than 100 countries. Sales teams across these regions work diligently to ensure that healthcare professionals and consumers alike have access to their products. Meanwhile, the company's commitment to innovation helps it remain responsive in rapidly evolving medical fields. The sales and marketing strategies are finely tuned to address regional disparities, leveraging local insights to maximize market penetration and bolster growth. Ultimately, Bausch Health Companies Inc. thrives by bridging high-quality health solutions with unmet global needs, seeking to leave a lasting impact on the lives it touches.

BHC Intrinsic Value
92.15 CAD
Undervaluation 90%
Intrinsic Value
Price

See Also

What is Bausch Health Companies Inc's Other Non-Cash Items?
Other Non-Cash Items
8m USD

Based on the financial report for Sep 30, 2025, Bausch Health Companies Inc's Other Non-Cash Items amounts to 8m USD.

What is Bausch Health Companies Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
-38%

Over the last year, the Other Non-Cash Items growth was -98%.

Back to Top